We are live on ! Find out more
CMTA

Clementia Pharmaceuticals Inc.
CMTA

Delisted

CMTA was delisted on the 17th of April, 2019.

Back to rankings

37 hedge funds and large institutions have $410M invested in Clementia Pharmaceuticals Inc. in 2017 Q4 according to their latest regulatory filings, with 6 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 14 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 5

16% more capital invested

Capital invested by funds: $353M → $410M (+$56M)

18% less funds holding

Funds holding: 45 → 37 (-8)

57% less first-time investments, than exits

New positions opened: 6 | Existing positions closed: 14

Holders
37
Holders Change
-8
Holders Change %
-17.78%
% of All Funds
0.84%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
% of All Funds
0.02%
New
6
Increased
10
Reduced
5
Closed
14
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Wellington Management Group
Wellington Management Group
Massachusetts
+$20.4M
2
Federated Hermes
Federated Hermes
Pennsylvania
+$11.4M
3
Janus Henderson Group
Janus Henderson Group
United Kingdom
+$5.91M
4
JP Morgan Chase
JP Morgan Chase
New York
+$880K
5
SAM
Sectoral Asset Management
Quebec, Canada
+$753K

Top Sellers

Rank Fund Capital Flow
1
DM
Deerfield Management
New York
-$7.81M
2
PA
Perceptive Advisors
New York
-$6.29M
3
ACH
ArrowMark Colorado Holdings
Colorado
-$3.86M
4
Millennium Management
Millennium Management
New York
-$3.04M
5
WMSA
Weiss Multi-Strategy Advisers
New York
-$2.55M
Name Holding Trade Value Shares
Change 		Change in
Stake
JGC
26
J. Goldman & Co
New York
$488K +$430K +25,692 New
BC
27
Birchview Capital
Vermont
$418K – – –
Morgan Stanley
28
Morgan Stanley
New York
$411K -$769K -45,973 -68%
Geode Capital Management
29
Geode Capital Management
Massachusetts
$288K – – –
Northern Trust
30
Northern Trust
Illinois
$205K +$181K +10,793 New
Millennium Management
31
Millennium Management
New York
$196K -$3.04M -181,655 -95%
AAMU
32
Amundi Asset Management US
Massachusetts
$87K +$77K +4,600 New
PCM
33
Prelude Capital Management
New York
$64K +$3.6K +215 +7%
FDCDDQ
34
Federation des caisses Desjardins du Quebec
Quebec, Canada
$19K – – –
UBS Group
35
UBS Group
Switzerland
$13K +$9.49K +567 +359%
Deutsche Bank
36
Deutsche Bank
Germany
$1K -$117K -7,000 -99%
DM
37
Deerfield Management
New York
– -$7.81M -462,387 Closed
PA
38
Perceptive Advisors
New York
– -$6.29M -352,250 Closed
ACH
39
ArrowMark Colorado Holdings
Colorado
– -$3.86M -228,323 Closed
Neuberger Berman Group
40
Neuberger Berman Group
New York
– -$1.69M -100,000 Closed
MWNA
41
Marshall Wace North America
New York
– -$1.61M -94,682 Closed
Susquehanna International Group
42
Susquehanna International Group
Pennsylvania
– -$729K -43,191 Closed
WAM
43
Wolverine Asset Management
Illinois
– -$506K -30,000 Closed
Point72 Asset Management
44
Point72 Asset Management
Connecticut
– -$506K -29,959 Closed
NFA
45
Nationwide Fund Advisors
Ohio
– -$427K -25,300 Closed
SIM
46
Spark Investment Management
New York
– -$410K -24,300 Closed
Tudor Investment Corp
47
Tudor Investment Corp
Connecticut
– -$405K -24,000 Closed
PPA
48
Parametric Portfolio Associates
Washington
– -$338K -20,018 Closed
PHK
49
Point72 Hong Kong
Hong Kong
– -$82K -4,860 Closed
TRCT
50
Tower Research Capital (TRC)
New York
– -$3K -200 Closed
1
2
3

CMTA Hedge Fund Activity: Q4 2017 in Review

37 of the 4,409 institutional investors tracked by Wall St. Rank reported a position in Clementia Pharmaceuticals Inc. (CMTA) for Q4 2017, worth a combined $410M — up 16% from $353M a quarter earlier.

Sellers outnumbered buyers: 14 funds closed out of CMTA and 6 opened new positions — a net loss of 8 holders — while 5 trimmed existing stakes and 10 added.

The largest buyer was Wellington Management Group, adding an estimated $20.4M. The largest seller was Deerfield Management, exiting entirely with an estimated $7.81M sold.

  • 37 institutional investors held Clementia Pharmaceuticals Inc. (CMTA) as of Q4 2017, down from 45 in Q3 2017.
  • Funds reported $410M of Clementia Pharmaceuticals Inc. stock for Q4 2017, up 16% quarter-over-quarter.
  • 6 funds opened new Clementia Pharmaceuticals Inc. positions in Q4 2017 and 14 closed out, a net change of -8 holders.
  • The largest Clementia Pharmaceuticals Inc. buyer in Q4 2017 was Wellington Management Group, an estimated $20.4M added.
  • The largest Clementia Pharmaceuticals Inc. seller in Q4 2017 was Deerfield Management, an estimated $7.81M sold.

Based on aggregated 13F filings for Q4 2017.